Viracta Therapeutics Inc (VIRX)
0.8102
-0.03
(-3.55%)
USD |
NASDAQ |
May 03, 16:00
0.822
+0.01
(+1.46%)
After-Hours: 20:00
Viracta Therapeutics Total Liabilities (Quarterly): 38.37M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.37M |
| September 30, 2023 | 36.43M |
| June 30, 2023 | 36.08M |
| March 31, 2023 | 34.67M |
| December 31, 2022 | 34.89M |
| September 30, 2022 | 14.39M |
| June 30, 2022 | 12.15M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.78M |
| December 31, 2021 | 14.18M |
| September 30, 2021 | 12.56M |
| June 30, 2021 | 11.58M |
| March 31, 2021 | 11.46M |
| December 31, 2020 | 94.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.46M
Minimum
Mar 2021
94.50M
Maximum
Dec 2020
28.00M
Average
14.39M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| XOMA Corp | 145.58M |
| Marinus Pharmaceuticals Inc | 154.14M |
| Cartesian Therapeutics Inc | 745.23M |
| Adial Pharmaceuticals Inc | 0.6531M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.69M |
| Shareholders Equity (Quarterly) | 18.32M |